Turkish League Against Rheumatism (TLAR) Recommendations for the Pharmacological management of Rheumatoid Arthritis: 2018 Update Under Guidance of Current Recommendations


Creative Commons License

Ataman S., Sunar I., Yilmaz G., BODUR H., Nas K., Ayhan F. F., ...Daha Fazla

ARCHIVES OF RHEUMATOLOGY, cilt.33, sa.3, ss.251-272, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 33 Sayı: 3
  • Basım Tarihi: 2018
  • Doi Numarası: 10.5606/archrheumatol.2018.6911
  • Dergi Adı: ARCHIVES OF RHEUMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.251-272
  • Anahtar Kelimeler: Disease modifying anti-rheumatic drugs, management, rheumatoid arthritis, treatment recommendations, Turkish League Against Rheumatism, MODIFYING ANTIRHEUMATIC DRUGS, NECROSIS-FACTOR INHIBITOR, LOW DISEASE-ACTIVITY, ADALIMUMAB PLUS METHOTREXATE, JOINT PROTECTION PROGRAM, HEAD-TO-HEAD, DOUBLE-BLIND, INADEQUATE RESPONSE, EULAR RECOMMENDATIONS, AMERICAN-COLLEGE
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Objectives: This study aims to report the assessment of the Turkish League Against Rheumatism (TLAR) expert panel on the compliance and adaptation of the European League Against Rheumatism (EULAR) 2016 recommendations for the management of rheumatoid arthritis (RA) in Turkey.